Rating Agencies

Share recommendations

Made with ❤ von BGFL
#BGFLapp * beta

Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.

14.05.2024 09:01AM
Study issued by NuWays AG

q.beyond AG (von NuWays AG): Kaufen

Kaufen
Strong Q1 figures hint towards successful transformation/ chg. Yesterday, q.beyond released a strong set of Q1 figures, which exceeded ours and streets profitability estimates as efficiency measures bore fruit despite rather muted top-line growth. In detail: Q1 sales increased slightly by 1.1% yoy to € 47.1m (eNuW: €47.5m, eCons: &e [ … ]
13.05.2024 11:41AM

Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research has published a research update on Schloss Wachenheim AG (ISIN: DE0007229007). Analyst Simon Scholes reiterated his BUY rating and maintained his EUR 22.00 price target. Abstract: Q3 23/24 sales climbed 5.6% to €87.1m (Q3 22/23: €82.5m) as price rises and positive product mix and currency effects outweighe [ … ]
10.05.2024 12:41PM

MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 62,00 auf EUR 81,00. Zusammenfassung: Die vorläufigen Ergebnisse entsprachen weitgehend unseren Erwartungen. Der JE23 Nettoinventa [ … ]
10.05.2024 09:07AM
Study issued by NuWays AG

ZEAL Network SE (von NuWays AG): Kaufen

Kaufen
Staggering Q1 kicks off new growth phase; chg est. & PT On Wednesday, ZEAL released staggering Q1 results above expectations with strong sales growth and better than expected profitability. Moreover, ZEAL substantially improved marketing efficiency which drove customer growth to record levels. In detail: Strong Lottery business: Lottery b [ … ]
10.05.2024 09:02AM
Study issued by NuWays AG

R. STAHL AG (von NuWays AG): Kaufen

Kaufen
Final Q1 out // Good start into 2024; chg. est. Topic: R. Stahl reported a solid final Q1 underpinning the strong demand for electrical explosion protection solutions, which should continue due to favorable structural trends. Management confirmed FY24e guidance, which looks well in reach (eNuW). To recap, Q1 sales grew 8.5% yoy to € 84.7 [ … ]
07.05.2024 09:01AM
Study issued by NuWays AG

q.beyond AG (von NuWays AG): Kaufen

Kaufen
Q1 figures set to display operational improvements / chg. q.beyond's Q1 figures, which will be released on May 13th, are seen to provide investors with confidence regarding the company’s outlook. While top-line growth is expected to come in rather muted, the imposed efficiency measures should already become visible on the bottom-line. Q [ … ]
06.05.2024 09:01AM
Study issued by NuWays AG

elumeo SE (von NuWays AG): Halten

Halten
Mixed Q4 // Weaker-than-expected guidance; est. & PT chg. elumeo published mixed Q4’23 that continue to be affected by a lingering macroeconomic slowdown. Here are our key takeaways: The company’s FY sales were slightly better than feared, but still burdened by muted consumer sentiment in the eurozone. Sales for FY came in fla [ … ]
30.04.2024 03:37PM

M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG (ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 18,00. Zusammenfassung: Die vorläufigen Ergebnisse für das Jahr 2023 zeigten erneut ein starkes Ergebnis im Segment Beauty. A [ … ]
29.04.2024 09:12AM
Study issued by NuWays AG

bet-at-home.com AG (von NuWays AG): Halten

Halten
Final FY23 in line // uncertainty from indicative decision Topic: bet-at-home reported final FY23 figures fully in line with prelims. Importantly, the report provide us with an update regarding receivables and liabilities against the Entertainment as well as regarding customer claims in Austria and Germany. In detail: Sales came in at € [ … ]
29.04.2024 09:01AM
Study issued by NuWays AG

MAX Automation SE (von NuWays AG): Kaufen

Kaufen
MAX achieved attractive sales price for MA micro; chg. est. Topic: MAX Automation has come to an agreement on the divestment of its subsidiary MA micro with an attractive purchase price, sale of MA micro anticipated in the second half of FY24e. MAX Automation announced the sale of MA micro (intention was announced in September 2023), which wa [ … ]

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
          Rating Agencies          
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL